6 Red Days In A Row: Albemarle Stock Is Down 15%
A recent slide in the specialty chemical stock prompts a closer look at the numbers.
Albemarle (ALB) stock has now moved lower for 6 consecutive trading days, losing a cumulative 15%. That streak has erased about $2.3 billion from the company’s market value, which now stands at about $13 billion.
The Streak Next To The S&P 500
Here is how ALB stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | ALB | S&P 500 |
|---|---|---|
| 1D | -3.5% | -0.4% |
| 6D (Current Streak) | -15.2% | -1.6% |
| 1M (21D) | -18.0% | -2.5% |
| 3M (63D) | -33.9% | 0.5% |
| YTD 2026 | -22.0% | 10.3% |
| 2025 | 67.7% | 16.4% |
| 2024 | -39.5% | 23.3% |
| 2023 | -32.8% | 24.2% |
Is this move about the company or the market?
The recent decline is mostly this stock’s own story. Over the same 6 trading days, the S&P 500 returned -1.6%. The streak itself is not unique; 12 other S&P 500 stocks are currently on losing streaks of 6 days or more.
The fundamental picture is mixed. Revenue over the last twelve months grew 18.3%, ahead of the 6.9% median for S&P 500 Materials stocks. Its operating margin of 13.7% is also just above the 13.4% median among S&P 500 Materials stocks. However, the company’s 3-year average annual revenue growth is -12.5%. Albemarle trades at about $109.47 a share as of 9/16/2026.
What does a streak like this actually mean?
A streak is not an instruction to buy or sell. It is a piece of information, telling you that a stock has captured attention and is showing momentum. The disciplined response is not to blindly react to the drop, but to use the discount as a trigger to re-evaluate the underlying business.
The new price is an opportunity to check the business against its valuation. The numbers here provide a starting point for that work, comparing the company’s recent performance against its longer-term results and its peers.
Such a drawdown poses an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
And for anyone who would rather back the theme than one company’s story, a materials ETF like XLB holds the whole group, not the single stock. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
A Slide Like This Is Why Diversification Exists
Watching one stock fall day after day is the clearest lesson the market teaches about single-name risk. Whether this particular decline is an opportunity or a warning, the deeper point is the same: no one name should be able to do this to your portfolio.
The Trefis High Quality (HQ) Portfolio is built on that principle: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Study the slide; spread the risk.